Embody vs Lttl

Choose Embody if…

• +About $339 a year less than Lttl for compounded semaglutide at standing prices (one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
• +Lists oral compounded tirzepatide, which Lttl doesn't price
• +Publishes its full state list (50 states)

What to weigh up

• −The $79 rate is an auto-applied promo 'locked forever'; the terms list $199/mo and reviewers allege the lock isn't honored
• −Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
• −Pharmacy partners not publicly named — compounding source transparency is limited

Choose Lttl if…

• +Accepts FSA/HSA cards
• +Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout
• +Flat dose pricing: 'Same price at every dose,' so moving to a higher dose does not raise the monthly bill

What to weigh up

• −About $339 a year more than Embody for compounded semaglutide (one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
• −No published state list; confirm yours at signup
• −Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)